Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease. (Q37525969)
Jump to navigation
Jump to search
scientific article published on January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease. |
scientific article published on January 2009 |
Statements
Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease (English)
Bin Zhou
Kenichi Yoshimura
Masanori Fukushima
1 January 2009